Cargando…

Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis

BACKGROUND: Huntington's Disease (HD) is a relentlessly progressive genetic neurodegenerative disorder with characteristic motor, psychiatric, and behavioral abnormalities that inevitably results in severe disability and death. Many patients have multiple hospital admissions during the disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peball, Marina, Heim, Beatrice, Ellmerer, Philipp, Frank, Florian, Busin, Nadia, Galffy, Matyas, Djamshidian, Atbin, Seppi, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274354/ https://www.ncbi.nlm.nih.gov/pubmed/35844271 http://dx.doi.org/10.1002/mdc3.13459

Ejemplares similares

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease
por: Peball, Marina, et al.
Publicado: (2023)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
por: Heim, Beatrice, et al.
Publicado: (2022)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Birds of a Feather Flock Together: Disadvantageous Decision Making in Augmented Restless Legs Syndrome Patients with and without Impulse Control Disorders
por: Heim, Beatrice, et al.
Publicado: (2021)

Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Augmentation in restless legs syndrome: an eye tracking study on emotion processing
por: Ellmerer, Philipp, et al.
Publicado: (2020)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

Cognitive dysfunction 1 year after COVID‐19: evidence from eye tracking
por: Carbone, Federico, et al.
Publicado: (2022)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

Neuropsychiatry of Huntington's disease
por: Rosenblatt, Adam
Publicado: (2007)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye‐Tracking Study
por: Carbone, Federico, et al.
Publicado: (2021)

Archer Milton Huntington
por: Gilman Proske, Beatrice, 1899-
Publicado: (1963)

Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
por: Fukuoka, Masashi, et al.
Publicado: (2018)

Absence of Acanthocytosis in Huntington’s Disease-like 2: A Prospective Comparison with Huntington’s Disease
por: Anderson, David G., et al.
Publicado: (2017)

Humanistic Burden of Huntington Disease: Evidence From the Huntington Disease Burden of Illness Study
por: Rodriguez Santana, Idaira, et al.
Publicado: (2022)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

AMPK amplifies Huntington's disease
por: Short, Ben
Publicado: (2011)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Treatment of Irritability in Huntington’s Disease
por: van Duijn, Erik
Publicado: (2010)

Plants and phytochemicals for Huntington's disease
por: Choudhary, Sunayna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1dp07vtbq8gc1732fa2s9lrn4o